Cargando…

Pharmacogenomics in Parkinson’s disease: which perspective for developing a personalized medicine?

Detalles Bibliográficos
Autores principales:	Ciccacci, Cinzia, Borgiani, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263000/ https://www.ncbi.nlm.nih.gov/pubmed/30531077 http://dx.doi.org/10.4103/1673-5374.243706

Ejemplares similares

Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG)
por: Bienfait, Karina, et al.
Publicado: (2021)

Pharmacogenetics and pharmacogenomics in glaucoma therapeutics: the way to personalized therapy
por: Liao, Shiyu, et al.
Publicado: (2023)

Deciphering next-generation pharmacogenomics: an information technology perspective
por: Potamias, George, et al.
Publicado: (2014)

Pharmacogenomics and Personalized Medicine
por: Cecchin, Erika, et al.
Publicado: (2020)

Pharmacogenomics and Personalized Medicine for Infectious Diseases
por: Ganguly, Nirmal Kumar, et al.
Publicado: (2013)

The implications of pharmacogenomics in oncology
por: Latimer, Jean J.
Publicado: (2023)

Human pharmacogenomics: The development of a science
por: Kalow, Werner
Publicado: (2004)

Pharmacogenomics in the era of personalised medicine
por: White, Cassandra, et al.
Publicado: (2022)

Pharmacogenomics: the promise of personalized medicine.
por: Hood, Ernie
Publicado: (2003)

5. Pharmacogenomics and Personalized Medicine
por: Topić, Elizabeta
Publicado: (2008)

The intricate debate on neurodegeneration and neuroinflammation in Parkinson’s disease: which came first?
por: Cardinale, Antonella, et al.
Publicado: (2022)

Integrating epigenomics into pharmacogenomic studies
por: Zhang, Wei, et al.
Publicado: (2008)

Emerging strategies and applications of pharmacogenomics
por: Milos, Patrice M, et al.
Publicado: (2004)

Population Pharmacogenomics for Health Equity
por: Jordan, I. King, et al.
Publicado: (2023)

A Personal Perspective: Is Bullying Still a Problem in Medicine?
por: Taylor-Robinson, Simon D, et al.
Publicado: (2021)

Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy
por: Roosan, Don, et al.
Publicado: (2020)

Relevance of Pharmacogenomics to the Safe Use of Antimicrobials
por: Daly, Ann K.
Publicado: (2023)

Pharmacogenomics based precision medicine in gastroesophageal cancers: way to move forward?
por: Shah, Shrunjal, et al.
Publicado: (2020)

Pharmacogenomics and personalized medicine: lost in translation?
por: Hulot, Jean-Sébastien
Publicado: (2010)

Pharmacogenomics in Personalized Medicine and Drug Metabolism
por: Chang, Wei-Chiao
Publicado: (2014)

PharmCAT: A Pharmacogenomics Clinical Annotation Tool
por: Klein, Teri E., et al.
Publicado: (2017)

Cannabis Pharmacogenomics: A Path to Personalized Medicine
por: Babayeva, Mariana, et al.
Publicado: (2023)

Emerging Role of microRNAs and Long Non-Coding RNAs in Sjögren’s Syndrome
por: De Benedittis, Giada, et al.
Publicado: (2021)

Personalized medicine in breast cancer: pharmacogenomics approaches
por: Jeibouei, Shabnam, et al.
Publicado: (2019)

Pharmacogenomics in osteoporosis: Steps toward personalized medicine
por: Greene, Robert, et al.
Publicado: (2009)

The pharmacogenomics of pain management: prospects for personalized medicine
por: Ting, Sonya, et al.
Publicado: (2016)

Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine
por: Maagdenberg, Hedy, et al.
Publicado: (2016)

Pharmacogenomics of sickle cell disease: steps toward personalized medicine
por: Husain, Marium, et al.
Publicado: (2017)

Beyond patient-centered care: person-centered care for Parkinson’s disease
por: Buetow, Stephen A, et al.
Publicado: (2016)

Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosing
por: Bishop, Jeffrey R.
Publicado: (2021)

Perspectives for the association between olfactory disturbances and depression in Parkinson’s disease
por: Ilkiw, Jessica L., et al.
Publicado: (2019)

New perspectives in iron chelation therapy for the treatment of Parkinson’s disease
por: Nuñez, Marco T., et al.
Publicado: (2019)

Stem Cell Transplantation for Parkinson’s Disease: Current Challenges and Perspectives
por: Zeng, Xinlin, et al.
Publicado: (2022)

Telemedicine in the Management of Parkinson’s Disease: Achievements, Challenges, and Future Perspectives
por: Cubo, Esther, et al.
Publicado: (2022)

Parkinson’s Disease: From Pathogenesis to Pharmacogenomics
por: Cacabelos, Ramón
Publicado: (2017)

Personalizing Personalized Medicine: The Confluence of Pharmacogenomics, a Person’s Medication Experience and Ethics
por: Stratton, Timothy P., et al.
Publicado: (2023)

Personalized Medicine in Europe
por: Nimmesgern, E, et al.
Publicado: (2017)

Application of personalized medicine to chronic disease: a feasibility assessment
por: Dorfman, Ruslan, et al.
Publicado: (2013)

A path towards personalized medicine for autoinflammatory and related diseases
por: Miner, Jonathan J., et al.
Publicado: (2023)

Precision medicine: Clarity for the clinical and biological complexity of Alzheimer’s and Parkinson’s diseases
por: Montine, Thomas J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gtd8kg05adni4dln8oqe9ro49f